Komano J, Maruo S, Kurozumi K, Oda T, Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt’s lymphoma cell line Akata. J Virol. 1999;73(12):9827–31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gruhne B, Kamranvar SA, Masucci MG, Sompallae R. EBV and genomic instability–a new look at the role of the virus in the pathogenesis of Burkitt’s lymphoma. Semin Cancer Biol. 2009;19(6):394–400.

Article  PubMed  CAS  Google Scholar 

Vereide D, Sugden B. Proof for EBV’s sustaining role in Burkitt’s lymphomas. Semin Cancer Biol. 2009;19(6):389–93.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Guo Z, Shu Y, Zhou H, Wang H, Zhang W. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Eur J Cancer Prev. 2017;26(2):144–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Poling BC, Price AM, Luftig MA, Cullen BR. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis. Virology. 2017;512:113–23.

Article  PubMed  CAS  Google Scholar 

Kang D, Skalsky RL, Cullen BR. EBV BART MicroRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog. 2015;11(6): e1004979.

Article  PubMed  PubMed Central  Google Scholar 

Lepej SŽ, Matulić M, Gršković P, Pavlica M, Radmanić L, Korać P. miRNAs: EBV mechanism for escaping host’s immune response and supporting tumorigenesis. Pathogens. 2020;9(5):353. https://doi.org/10.3390/pathogens9050353.

Article  CAS  Google Scholar 

Min K, Lee SK. EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1. Int J Biol Sci. 2019;15(3):657–67.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Verhoeven Rob JA, Tong S, Zhang G, Zong J, Chen Y, Jin D-Y, et al. NF-κB signaling regulates expression of Epstein-Barr virus BART MicroRNAs and long noncoding RNAs in nasopharyngeal carcinoma. J Virol. 2016;90(14):6475–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology. 2009;386(2):387–97.

Article  PubMed  CAS  Google Scholar 

Wang M, Gu B, Chen X, Wang Y, Li P, Wang K. The function and therapeutic Potential of Epstein-Barr virus-encoded MicroRNAs in cancer. Molecular Therapy - Nucleic Acids. 2019;17:657–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kawanishi M. Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins. Nihon Rinsho. 1996;54(7):1848–54.

PubMed  CAS  Google Scholar 

Ma J, Nie K, Redmond D, Liu Y, Elemento O, Knowles DM, Tam W. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis. Leukemia. 2016;30(3):594–604.

Article  PubMed  CAS  Google Scholar 

Fachko DN, Chen Y, Skalsky RL. Epstein-Barr virus miR-BHRF1-3 targets the BZLF1 3’UTR and regulates the lytic cycle. J Virol. 2022;96(4): e0149521.

Article  PubMed  Google Scholar 

Li W, He C, Wu J, Yang D, Yi W. Epstein-Barr virus encodes miRNAs to assist host immune escape. J Cancer. 2020;11(8):2091–100.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Min K, Kim JY, Lee SK. Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2. Int J Biol Sci. 2020;16(4):694–707.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xia T, O’Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, et al. EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by EBV-mir-BHRF1-3. Can Res. 2008;68(5):1436–42.

Article  CAS  Google Scholar 

Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, et al. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agents Cancer. 2014;9(1):12.

Article  PubMed  PubMed Central  Google Scholar 

Zhang YM, Yu Y, Zhao HP. EBV-BART-6-3p and cellular microRNA-197 compromise the immune defense of host cells in EBV-positive Burkitt lymphoma. Mol Med Rep. 2017;15(4):1877–83.

Article  PubMed  CAS  Google Scholar 

Caetano BFR, Rocha VL, Rossini BC, Santos LDD, Oliveira DED. Epstein-Barr Virus miR-BARTs 7 and 9 modulate viral cycle, cell proliferation, and proteomic profiles in Burkitt lymphoma. Tumour Virus Research. 2024;17:200276. https://doi.org/10.1016/j.tvr.2023.200276.

Article  PubMed  CAS  Google Scholar 

Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun. 2022;13(1):866.

Article  PubMed  PubMed Central  Google Scholar 

Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, et al. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget. 2016;7(1):224–40.

Article  PubMed  Google Scholar 

Valiente-Echeverría F, Hermoso MA, Soto-Rifo R. RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity. Rev Med Virol. 2015;25(5):286–99.

Article  PubMed  Google Scholar 

Jin J, Sun T, Zhang M, Cheng J, Jia Gu, Huang L, Xiao M, Zhou J, Luo H. EBV-encoded MicroRNA-BART17-3p targets DDX3X and promotes EBV infection in EBV-associated T/natural killer–cell lymphoproliferative diseases. Open Forum Infect Dis. 2023. https://doi.org/10.1093/ofid/ofad516.

Article  PubMed  PubMed Central  Google Scholar 

Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A, et al. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer. 2010;126(6):1316–26.

Article  PubMed  CAS  Google Scholar 

Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S, De Falco G, Vigorito E, Leoncini L. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J. 2012;2(8):e84–e84. https://doi.org/10.1038/bcj.2012.29.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou L, Bu Y, Liang Y, Zhang F, Zhang H, Li S. Epstein-Barr Virus (EBV)-BamHI-A rightward transcript (BART)-6 and Cellular MicroRNA-142 synergistically compromise immune defense of host cells in EBV-positive Burkitt lymphoma. Med Sci Monit. 2016;22:4114–20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Kincaid RP, Bastin K, Fachko DN, Skalsky RL. MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation. PLoS Pathog. 2024;20(6):e1011970.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Di Lisio L, Sánchez-Beato M, Gómez-López G, Rodríguez ME, Montes-Moreno S, Mollejo M, Menárguez J, Martínez MA, Alves FJ, Pisano DG, Piris MA, Martínez N. MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2012;2(2):e57–e57. https://doi.org/10.1038/bcj.2012.1.

Article  PubMed  PubMed Central